ACM
LXRX icon

Aster Capital Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Aster Capital Management’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.78K Buy
+743
New +$1.45K ﹤0.01% 779
2025
Q3 		– Sell
-130,452
Closed -$123K – 1202
2025
Q2 		$123K Buy
+130,452
New +$84.5K 0.03% 474

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Aster Capital Management's LXRX Position: Q2 2026 in Review

Aster Capital Management opened a new position in Lexicon Pharmaceuticals (LXRX) in Q2 2026: 743 shares worth $1.78K. The stake represents ﹤0.01% of the portfolio and ranks #779 among its holdings. This is a return to the name: Aster Capital Management previously reported a position in LXRX as recently as Q2 2025.

Aster Capital Management first reported a position in LXRX in Q2 2025 and has held it in 2 quarters since. The position peaked at $123K in Q2 2025. 148 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

  • Aster Capital Management held 743 shares of Lexicon Pharmaceuticals worth $1.78K as of Q2 2026.
  • Lexicon Pharmaceuticals was a new Aster Capital Management position in Q2 2026.
  • Lexicon Pharmaceuticals made up ﹤0.01% of Aster Capital Management's portfolio in Q2 2026, its #779 holding.
  • Aster Capital Management first reported a position in Lexicon Pharmaceuticals in Q2 2025 and has held it in 2 quarters since.
  • Aster Capital Management's Lexicon Pharmaceuticals position peaked at $123K in Q2 2025.
  • 148 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.